{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T13:20:38Z","timestamp":1777209638249,"version":"3.51.4"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T00:00:00Z","timestamp":1733875200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T00:00:00Z","timestamp":1733875200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Urol Rep"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11934-024-01248-y","type":"journal-article","created":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T02:21:35Z","timestamp":1733883695000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Health-Related Quality of Life Across the Spectrum of Bladder Cancer: A Current Review"],"prefix":"10.1007","volume":"26","author":[{"given":"Kate A.","family":"Moody","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel S.","family":"Iofel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew B.","family":"Clements","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,12,11]]},"reference":[{"issue":"5","key":"1248_CR1","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.eururo.2021.01.032","volume":"79","author":"JW Catto","year":"2021","unstructured":"Catto JW, Downing A, Mason S, Wright P, Absolom K, Bottomley S, et al. Quality of life after bladder cancer: a cross-sectional survey of patient-reported outcomes. Eur Urol. 2021;79(5):621\u201332.","journal-title":"Eur Urol"},{"issue":"4","key":"1248_CR2","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1111\/bju.14047","volume":"121","author":"AB Smith","year":"2018","unstructured":"Smith AB, Jaeger B, Pinheiro LC, Edwards LJ, Tan HJ, Nielsen ME, et al. Impact of bladder cancer on health-related quality of life. BJU Int. 2018;121(4):549\u201357.","journal-title":"BJU Int"},{"key":"1248_CR3","first-page":"1383","volume":"21","author":"S Singer","year":"2013","unstructured":"Singer S, Ziegler C, Schwalenberg T, Hinz A, G\u00f6tze H, Schulte T. Quality of life in patients with muscle invasive and non-muscle invasive bladder cancer. Support Care Cancer. 2013;21:1383\u201393.","journal-title":"Support Care Cancer"},{"issue":"3","key":"1248_CR4","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/j.juro.2014.03.098","volume":"192","author":"C Fung","year":"2014","unstructured":"Fung C, Pandya C, Guancial E, Noyes K, Sahasrabudhe DM, Messing EM, et al. Impact of bladder cancer on health related quality of life in 1,476 older Americans: a cross-sectional study. J Urol. 2014;192(3):690\u20135.","journal-title":"J Urol"},{"issue":"3","key":"1248_CR5","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.suronc.2016.05.027","volume":"25","author":"LS Yang","year":"2016","unstructured":"Yang LS, Shan BL, Shan LL, Chin P, Murray S, Ahmadi N, et al. A systematic review and meta-analysis of quality of life outcomes after radical cystectomy for bladder cancer. Surg Oncol. 2016;25(3):281\u201397.","journal-title":"Surg Oncol"},{"issue":"8","key":"1248_CR6","doi-asserted-by":"publisher","first-page":"3607","DOI":"10.21873\/anticanres.16540","volume":"43","author":"M Tachibana","year":"2023","unstructured":"Tachibana M, Tsubouchi K, Fukuhara Y, Aoyagi C, Tominaga K, Gunge N, et al. Factors Related to Overactive Bladder-like Symptoms in Bladder Cancer. Anticancer Res. 2023;43(8):3607\u201313. https:\/\/doi.org\/10.21873\/anticanres.16540.","journal-title":"Anticancer Res"},{"issue":"1","key":"1248_CR7","doi-asserted-by":"publisher","first-page":"19.e7","DOI":"10.1016\/j.urolonc.2014.09.012","volume":"33","author":"S Schmidt","year":"2015","unstructured":"Schmidt S, Franc\u00e9s A, LorenteGarin JA, Juanpere N, LloretaTrull J, Bonfill X, et al. Quality of life in patients with non\u2013muscle-invasive bladder cancer: One-year results of a multicentre prospective cohort study. Urologic Oncology: Seminars and Original Investigations. 2015;33(1):19.e7-e5. https:\/\/doi.org\/10.1016\/j.urolonc.2014.09.012.","journal-title":"Urologic Oncology: Seminars and Original Investigations."},{"issue":"2","key":"1248_CR8","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.urology.2004.09.050","volume":"65","author":"K Yoshimura","year":"2005","unstructured":"Yoshimura K, Utsunomiya N, Ichioka K, Matsui Y, Terai A, Arai Y. Impact of superficial bladder cancer and transurethral resection on general health-related quality of life: an SF-36 survey. Urology. 2005;65(2):290\u20134.","journal-title":"Urology"},{"issue":"1","key":"1248_CR9","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1097\/ju.0000000000002941","volume":"209","author":"T Parisse","year":"2023","unstructured":"Parisse T, Reines K, Basak R, Mueller D, Teal R, Vu MB, et al. Patient and Provider Perception of Transurethral Resection of Bladder Tumor vs Chemoablation for Nonmuscle-invasive Bladder Cancer Treatment. J Urol. 2023;209(1):150\u201360. https:\/\/doi.org\/10.1097\/ju.0000000000002941.","journal-title":"J Urol"},{"issue":"2","key":"1248_CR10","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1111\/j.1442-2042.1996.tb00490.x","volume":"3","author":"DL Berry","year":"1996","unstructured":"Berry DL, Blumenstein BA, Magyary DL, Lamm DL, Crawford ED. Local Toxicity Patterns Associated with lntravesical bacillus Calmette-Gu\u00e9rin: A Southwest Oncology Group Study. Int J Urol. 1996;3(2):98\u2013100.","journal-title":"Int J Urol"},{"issue":"3","key":"1248_CR11","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1046\/j.1464-410X.1996.00134.x","volume":"78","author":"D Mack","year":"1996","unstructured":"Mack D, Frick J. Quality of life in patients undergoing bacille Calmette-Gu\u00e9rin therapy for superficial bladder cancer. Br J Urol. 1996;78(3):369\u201371.","journal-title":"Br J Urol"},{"issue":"1","key":"1248_CR12","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1111\/bju.14888","volume":"125","author":"A Jung","year":"2020","unstructured":"Jung A, Nielsen ME, Crandell JL, Palmer MH, Smith SK, Bryant AL, et al. Health-related quality of life among non-muscle-invasive bladder cancer survivors: a population-based study. BJU Int. 2020;125(1):38\u201348. https:\/\/doi.org\/10.1111\/bju.14888.","journal-title":"BJU Int"},{"issue":"1","key":"1248_CR13","doi-asserted-by":"publisher","first-page":"76.e9","DOI":"10.1016\/j.urolonc.2020.07.003","volume":"39","author":"DA Gonz\u00e1lez-Padilla","year":"2021","unstructured":"Gonz\u00e1lez-Padilla DA, Gonz\u00e1lez-D\u00edaz A, Guerrero-Ramos F, Rodr\u00edguez-Serrano A, Garc\u00eda-Jarabo E, Corona-laPuerta M, et al. Quality of life and adverse events in patients with nonmuscle invasive bladder cancer receiving adjuvant treatment with BCG, MMC, or chemohyperthermia. Urol Oncol. 2021;39(1):76.e9-e14.","journal-title":"Urol Oncol."},{"issue":"1","key":"1248_CR14","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.juro.2015.08.075","volume":"195","author":"A Yokomizo","year":"2016","unstructured":"Yokomizo A, Kanimoto Y, Okamura T, Ozono S, Koga H, Iwamura M, et al. Randomized controlled study of the efficacy, safety and quality of life with low dose bacillus Calmette-Gu\u00e9rin instillation therapy for nonmuscle invasive bladder cancer. J Urol. 2016;195(1):41\u20136.","journal-title":"J Urol"},{"issue":"3","key":"1248_CR15","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.juro.2013.03.097","volume":"190","author":"P Gontero","year":"2013","unstructured":"Gontero P, Oderda M, Mehnert A, Gurioli A, Marson F, Lucca I, et al. The impact of intravesical gemcitabine and 1\/3 dose Bacillus Calmette-Guerin instillation therapy on the quality of life in patients with nonmuscle invasive bladder cancer: results of a prospective, randomized, phase II trial. J Urol. 2013;190(3):857\u201362.","journal-title":"J Urol"},{"issue":"4","key":"1248_CR16","doi-asserted-by":"publisher","first-page":"e418","DOI":"10.1016\/j.clgc.2019.12.004","volume":"18","author":"E Cox","year":"2020","unstructured":"Cox E, Saramago P, Kelly J, Porta N, Hall E, Tan WS, et al. Effects of bladder cancer on UK healthcare costs and patient health-related quality of life: evidence from the BOXIT trial. Clin Genitourin Cancer. 2020;18(4):e418\u201342.","journal-title":"Clin Genitourin Cancer"},{"issue":"9","key":"1248_CR17","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1111\/j.1442-2042.2010.02584.x","volume":"17","author":"H Koga","year":"2010","unstructured":"Koga H, Ozono S, Tsushima T, Tomita K, Horiguchi Y, Usami M, et al. Maintenance intravesical bacillus Calmette-Gu\u00e9rin instillation for Ta, T1 cancer and carcinoma in situ of the bladder: Randomized controlled trial by the BCG Tokyo Strain Study Group. Int J Urol. 2010;17(9):759\u201366. https:\/\/doi.org\/10.1111\/j.1442-2042.2010.02584.x.","journal-title":"Int J Urol"},{"issue":"1","key":"1248_CR18","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.eururo.2018.09.005","volume":"75","author":"WS Tan","year":"2019","unstructured":"Tan WS, Panchal A, Buckley L, Devall AJ, Loubi\u00e8re LS, Pope AM, et al. Radiofrequency-induced Thermo-chemotherapy Effect Versus a Second Course of Bacillus Calmette-Gu\u00e9rin or Institutional Standard in Patients with Recurrence of Non\u2013muscle-invasive Bladder Cancer Following Induction or Maintenance Bacillus Calmette-Gu\u00e9rin Therapy (HYMN): A Phase III, Open-label. Randomised Controlled Trial European Urology. 2019;75(1):63\u201371. https:\/\/doi.org\/10.1016\/j.eururo.2018.09.005.","journal-title":"Randomised Controlled Trial European Urology"},{"issue":"1","key":"1248_CR19","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/JU.0000000000003981","volume":"212","author":"J Holzbeierlein","year":"2024","unstructured":"Holzbeierlein J, Bixler BR, Buckley DI, Chang SS, Holmes RS, James AC, et al. Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA\/ASCO\/SUO Guideline (2017; Amended 2020, 2024). J Urol. 2024;212(1):3\u201310. https:\/\/doi.org\/10.1097\/JU.0000000000003981.","journal-title":"J Urol"},{"issue":"9","key":"1248_CR20","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1002\/cncr.22556","volume":"109","author":"SM Gilbert","year":"2007","unstructured":"Gilbert SM, Wood DP, Dunn RL, Weizer AZ, Lee CT, Montie JE, et al. Measuring health-related quality of life outcomes in bladder cancer patients using the Bladder Cancer Index (BCI). Cancer. 2007;109(9):1756\u201362.","journal-title":"Cancer"},{"issue":"4","key":"1248_CR21","doi-asserted-by":"publisher","first-page":"e043266","DOI":"10.1136\/bmjopen-2020-043266","volume":"11","author":"SL Maibom","year":"2021","unstructured":"Maibom SL, Joensen UN, Poulsen AM, Kehlet H, Brasso K, R\u00f8der MA. Short-term morbidity and mortality following radical cystectomy: a systematic review. BMJ Open. 2021;11(4):e043266.","journal-title":"BMJ Open"},{"issue":"3","key":"1248_CR22","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.eururo.2021.09.018","volume":"81","author":"MB Clements","year":"2022","unstructured":"Clements MB, Atkinson TM, Dalbagni GM, Li Y, Vickers AJ, Herr HW, et al. Health-related Quality of Life for Patients Undergoing Radical Cystectomy: Results of a Large Prospective Cohort. Eur Urol. 2022;81(3):294\u2013304. https:\/\/doi.org\/10.1016\/j.eururo.2021.09.018.","journal-title":"Eur Urol"},{"issue":"21","key":"1248_CR23","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1001\/jama.2022.7393","volume":"327","author":"JWF Catto","year":"2022","unstructured":"Catto JWF, Khetrapal P, Ricciardi F, Ambler G, Williams NR, Al-Hammouri T, et al. Effect of Robot-Assisted Radical Cystectomy With Intracorporeal Urinary Diversion vs Open Radical Cystectomy on 90-Day Morbidity and Mortality Among Patients With Bladder Cancer: A Randomized Clinical Trial. JAMA. 2022;327(21):2092\u2013103. https:\/\/doi.org\/10.1001\/jama.2022.7393.","journal-title":"JAMA"},{"issue":"5","key":"1248_CR24","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1097\/JU.0000000000003201","volume":"209","author":"MB Clements","year":"2023","unstructured":"Clements MB, Beech BB, Atkinson TM, Dalbagni GM, Li Y, Vickers AJ, et al. Health-related quality of life after robotic-assisted vs open radical cystectomy: analysis of a randomized trial. J Urol. 2023;209(5):901\u201310.","journal-title":"J Urol"},{"issue":"7","key":"1248_CR25","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1007\/s00345-022-04029-9","volume":"40","author":"M Vejlgaard","year":"2022","unstructured":"Vejlgaard M, Maibom SL, Joensen UN, Thind PO, Rohrsted M, Aasvang EK, et al. Quality of life and secondary outcomes for open versus robot-assisted radical cystectomy: a double-blinded, randomised feasibility trial. World J Urol. 2022;40(7):1669\u201377.","journal-title":"World J Urol"},{"key":"1248_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13643-017-0547-y","volume":"6","author":"SV Lauridsen","year":"2017","unstructured":"Lauridsen SV, T\u00f8nnesen H, Jensen BT, Neuner B, Thind P, Thomsen T. Complications and health-related quality of life after robot-assisted versus open radical cystectomy: a systematic review and meta-analysis of four RCTs. Syst Rev. 2017;6:1\u201312.","journal-title":"Syst Rev"},{"issue":"8","key":"1248_CR27","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1111\/iju.14005","volume":"26","author":"S Kimura","year":"2019","unstructured":"Kimura S, Iwata T, Foerster B, Fossati N, Briganti A, Nasu Y, et al. Comparison of perioperative complications and health-related quality of life between robot-assisted and open radical cystectomy: a systematic review and meta-analysis. Int J Urol. 2019;26(8):760\u201374.","journal-title":"Int J Urol"},{"key":"1248_CR28","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.euros.2023.01.009","volume":"50","author":"S Tappero","year":"2023","unstructured":"Tappero S, Dell\u2019Oglio P, Cerruto MA, Sanchez Salas R, Buisan Rueda O, Simone G, et al. Ileal Conduit Versus Orthotopic Neobladder Urinary Diversion in Robot-assisted Radical Cystectomy: Results from a Multi-institutional Series. Eur Urology Open Sci. 2023;50:47\u201356. https:\/\/doi.org\/10.1016\/j.euros.2023.01.009.","journal-title":"Eur Urology Open Sci"},{"key":"1248_CR29","doi-asserted-by":"crossref","unstructured":"Wong CH-m, Ko IC-h, Kang SH, Kitamura K, Horie S, Muto S, et al. Long-term outcomes of orthotopic neobladder versus ileal conduit urinary diversion in robot-assisted radical cystectomy (rarc): multicenter results from the asian rarc consortium. Annals of Surgical Oncology. 2024;27:1\u20139.","DOI":"10.1245\/s10434-024-15396-5"},{"key":"1248_CR30","doi-asserted-by":"publisher","first-page":"855546","DOI":"10.3389\/fonc.2022.855546","volume":"12","author":"S Siracusano","year":"2022","unstructured":"Siracusano S, Zaka A, Bassi P, Gontero P, Mearini E, Imbimbo C, et al. Quality-of-life outcomes in female patients with ileal conduit or orthotopic neobladder urinary diversion: 6-month results of a multicenter prospective study. Front Oncol. 2022;12:855546.","journal-title":"Front Oncol"},{"issue":"5","key":"1248_CR31","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1111\/bju.12440","volume":"113","author":"V Singh","year":"2014","unstructured":"Singh V, Yadav R, Sinha RJ, Gupta DK. Prospective comparison of quality-of-life outcomes between ileal conduit urinary diversion and orthotopic neobladder reconstruction after radical cystectomy: a statistical model. BJU Int. 2014;113(5):726\u201332.","journal-title":"BJU Int"},{"issue":"1","key":"1248_CR32","first-page":"5","volume":"2011","author":"C Shih","year":"2011","unstructured":"Shih C, Porter MP. Health-related quality of life after cystectomy and urinary diversion for bladder cancer. Adv Urology. 2011;2011(1):5.","journal-title":"Adv Urology"},{"key":"1248_CR33","doi-asserted-by":"publisher","first-page":"564779","DOI":"10.3389\/fonc.2020.564779","volume":"10","author":"H Ding","year":"2020","unstructured":"Ding H, Fan N, Ning Z, Ma D. Trimodal therapy vs radical cystectomy for muscle-invasive bladder cancer: a meta-analysis. Front Oncol. 2020;10:564779.","journal-title":"Front Oncol"},{"key":"1248_CR34","doi-asserted-by":"publisher","unstructured":"Ditonno F, Veccia A, Montanaro F, Pettenuzzo G, Franco A, Manfredi C, et al. Trimodal therapy vs radical cystectomy in patients with muscle-invasive bladder cancer: a systematic review and meta-analysis of comparative studies. BJU International. 2024. https:\/\/doi.org\/10.1111\/bju.16366.","DOI":"10.1111\/bju.16366"},{"issue":"5","key":"1248_CR35","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1097\/01.ju.0000093721.23249.c3","volume":"170","author":"AL Zietman","year":"2003","unstructured":"Zietman AL, Sacco D, Skowronski URI, Gomery P, Kaufman DS, Clark JA, et al. Organ Conservation in Invasive Bladder Cancer by Transurethral Resection, Chemotherapy and Radiation: Results of a Urodynamic and Quality of Life Study on Long-term Survivors. J Urol. 2003;170(5):1772\u20136. https:\/\/doi.org\/10.1097\/01.ju.0000093721.23249.c3.","journal-title":"J Urol"},{"issue":"1","key":"1248_CR36","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.clgc.2018.09.023","volume":"17","author":"TJ Royce","year":"2019","unstructured":"Royce TJ, Feldman AS, Mossanen M, Yang JC, Shipley WU, Pandharipande PV, et al. Comparative Effectiveness of Bladder-preserving Tri-modality Therapy Versus Radical Cystectomy for Muscle-invasive Bladder Cancer. Clin Genitourin Cancer. 2019;17(1):23-31.e3. https:\/\/doi.org\/10.1016\/j.clgc.2018.09.023.","journal-title":"Clin Genitourin Cancer"},{"issue":"5","key":"1248_CR37","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1016\/j.ijrobp.2016.08.023","volume":"96","author":"KS Mak","year":"2016","unstructured":"Mak KS, Smith AB, Eidelman A, Clayman R, Niemierko A, Cheng J-S, et al. Quality of Life in Long-term Survivors of Muscle-Invasive Bladder Cancer. Int J Radiation Oncol Biol Phys. 2016;96(5):1028\u201336. https:\/\/doi.org\/10.1016\/j.ijrobp.2016.08.023.","journal-title":"Int J Radiation Oncol Biol Phys"}],"container-title":["Current Urology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11934-024-01248-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11934-024-01248-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11934-024-01248-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T19:03:41Z","timestamp":1767985421000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11934-024-01248-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,11]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1248"],"URL":"https:\/\/doi.org\/10.1007\/s11934-024-01248-y","relation":{},"ISSN":["1527-2737","1534-6285"],"issn-type":[{"value":"1527-2737","type":"print"},{"value":"1534-6285","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,11]]},"assertion":[{"value":"16 October 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Matthew B. Clements was the PI for Lahey for the SunRISE3 trial which was sponsored by Janssen Pharmaceuticals. He received no financial incentives related to participation in the study and has no other relevant ties to the sponsor. Additionally the study has now been closed to enrollment in the US and therefore is not currently underway at our site.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"All reported studies\/experiments with human subjects performed by the authors were performed in accordance with all applicable ethical standards including the Helsinki Declaration and its amendments, institutional\/national research committee standards, and international\/national\/institutional guidelines.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"21"}}